Sarcoidosis, An Issue of Clinics in Chest Medicine

Dr. Baughman is Professor of Medicine at the University of Cincinnati. After completing undergraduate training at Yale University, he received his medical degree from Case Western Reserve School of Medicine. He joined the Internal Medicine staff at the University of Cincinnati after completing both an Internal Medicine residency and fellowship training in pulmonary diseases at the University of Cincinnati. His major research interests include: the treatment of sarcoidosis and bronchoalveolar lavage. Along with his long time collaborator Dr. Elyse Lower, he has developed several novel treatments for sarcoidosis, including methotrexate, thalidomide, leflunomide, and infliximab. Current studies include treatments for sarcoidosis associated fatigue and pulmonary hypertension due to sarcoidosis. He is on the editorial board of multiple subspecialty journals, and his publications include over 300 original papers mostly regarding various aspects of sarcoidosis and over 70 review articles and/or book chapters. He has edited several books on sarcoidosis and other interstitial lung diseases. He is on the editorial board of several journals, including American Journal of Respiratory and Critical Care Medicine and Chest. In addition, Dr. Baughman is the recent editor of books on sarcoidosis, interstitial lung disease, and ventilator associated pneumonia. He has been an active member of World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) since its inception and is President Emeritus.

Epidemiology of Sarcoidosis
Diagnosis of Pulmonary Sarcoidosis
Role of Bronchoscopy in Diagnosis of Sarcoidosis
Biomarkers in Sarcoidosis: Beginning of a New Era?
Monitoring of Sarcoidosis
Ocular Sarcoidosis
Cutaneous Sarcoidosis
Neurosarcoidosis and Neurologic Complications of Sarcoidosis Treatment
Cardiac Sarcoidosis
Hematologic and Oncologic Aspects of Sarcoidosis: Some of the Least Studied but Most Common Dilemmas
Anti-inflammatory Therapy for Sarcoidosis
Health-Related Quality of Life Assessment in Sarcoidosis
Predictors of Mortality in Sarcoidosis
Sarcoidosis-Associated Pulmonary Hypertension
Fibrotic Pulmonary Sarcoidosis